Yanli An1
Qiusha Tang- 1Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China
- 2Research Institute for Reproductive Health and Genetic Diseases, The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, China
- 3School of Medicine, Southeast University, Nanjing, China
- 4Department of Tuberculosis, The Second Affiliated Hospital of Southeast University (The Second Hospital of Nanjing), Nanjing, China
- 5Department of Neurosurgery, Nanjing Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China
A Corrigendum on
Facile assembly of thermosensitive liposomes for active targeting imaging and synergetic chemo-/magnetic hyperthermia therapy
by An Y, Yang R, Wang X, Han Y, Jia G, Hu C, Zhang Z, Liu D and Tang Q (2021). Front. Bioeng. Biotechnol. 9:691091. doi: 10.3389/fbioe.2021.691091
In the published article, there was an error in Figure 4 as published. The IHC staining images of Figure 4B for “5” does not correspond to the correct groups. The corrected Figure 4 and its caption FIGURE 4 Targeted therapy of CD90@17-AAG/TMs in different groups. (A) H&E staining of the tumor tissues in different groups (×20, black arrows represent Fe3O4 nanoparticles, red arrows represent tumor tissues, and blue arrows represent necrotic tissue). (B) CD90 IHC staining of the tumor tissues in different groups (×40, green arrows represent the CD90-positive cells). 1. NS, 2. NS + AMF, 3. TMs, 4. TMs + AMF, 5. TSLs, 6. 17-AAG/TSLs, 7. 17-AAG/TMs + AMF, and 8.CD90@17-AAG/TMs + AMF. appear below.
Figure 4. Targeted therapy of CD90@17-AAG/TMs in different groups. (A) H&E staining of the tumor tissues in different groups (×20, black arrows represent Fe3O4 nanoparticles, red arrows represent tumor tissues, and blue arrows represent necrotic tissue). (B) CD90 IHC staining of the tumor tissues in different groups (×40, green arrows represent the CD90-positive cells). 1. NS, 2. NS + AMF, 3. TMs, 4. TMs + AMF, 5. TSLs, 6. 17-AAG/TSLs, 7. 17-AAG/TMs + AMF, and 8.CD90@17-AAG/TMs + AMF.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: CD90, combined therapy, imaging, LCSCs, hyperthermia therapy
Citation: An Y, Yang R, Wang X, Han Y, Jia G, Hu C, Zhang Z, Liu D and Tang Q (2025) Corrigendum: Facile assembly of thermosensitive liposomes for active targeting imaging and synergetic chemo-/magnetic hyperthermia therapy. Front. Bioeng. Biotechnol. 13:1579340. doi: 10.3389/fbioe.2025.1579340
Received: 19 February 2025; Accepted: 09 April 2025;
Published: 06 May 2025.
Edited by:
Maria Gazouli, National and Kapodistrian University of Athens, GreeceReviewed by:
Sandrine Cammas-Marion, Centre National de la Recherche Scientifique (CNRS), FranceCopyright © 2025 An, Yang, Wang, Han, Jia, Hu, Zhang, Liu and Tang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qiusha Tang, cGFueWl4aS10cXNAMTYzLmNvbQ==